192 related articles for article (PubMed ID: 32590186)
1. Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: A review over the last 5 years.
Aris P; Robatjazi S; Nikkhahi F; Amin Marashi SM
J Glob Antimicrob Resist; 2020 Sep; 22():625-630. PubMed ID: 32590186
[TBL] [Abstract][Full Text] [Related]
2. Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam.
Berglund B; Hoang NTB; Tärnberg M; Le NK; Svartström O; Khu DTK; Nilsson M; Le HT; Welander J; Olson L; Larsson M; Nilsson LE; Hanberger H
Int J Antimicrob Agents; 2018 May; 51(5):789-793. PubMed ID: 29180281
[TBL] [Abstract][Full Text] [Related]
3. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.
Zhu Y; Galani I; Karaiskos I; Lu J; Aye SM; Huang J; Yu HH; Velkov T; Giamarellou H; Li J
J Infect; 2019 Oct; 79(4):312-321. PubMed ID: 31374222
[TBL] [Abstract][Full Text] [Related]
5. The Middle East population puzzle.
Omran AR; Roudi F
Popul Bull; 1993 Jul; 48(1):1-40. PubMed ID: 12318382
[TBL] [Abstract][Full Text] [Related]
6. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á
Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N
J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
[TBL] [Abstract][Full Text] [Related]
8. Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an IS
Sonnevend Á; Ghazawi A; Hashmey R; Haidermota A; Girgis S; Alfaresi M; Omar M; Paterson DL; Zowawi HM; Pál T
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438945
[TBL] [Abstract][Full Text] [Related]
9. A middle east systematic review and meta-analysis of bacterial urinary tract infection among renal transplant recipients; Causative microorganisms.
Behzad D; Hakimeh A; Hossein R; Khaledi A
Microb Pathog; 2020 Nov; 148():104458. PubMed ID: 32835776
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis.
Narimisa N; Goodarzi F; Bavari S
Ann Clin Microbiol Antimicrob; 2022 Jun; 21(1):29. PubMed ID: 35765073
[TBL] [Abstract][Full Text] [Related]
12. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
[TBL] [Abstract][Full Text] [Related]
13. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
[TBL] [Abstract][Full Text] [Related]
14. Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.
Lalaoui R; Bakour S; Livnat K; Assous MV; Diene SM; Rolain JM
Microb Drug Resist; 2019; 25(1):63-71. PubMed ID: 30129868
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-mediated colistin resistance in Escherichia coli from the Arabian Peninsula.
Sonnevend Á; Ghazawi A; Alqahtani M; Shibl A; Jamal W; Hashmey R; Pal T
Int J Infect Dis; 2016 Sep; 50():85-90. PubMed ID: 27566913
[TBL] [Abstract][Full Text] [Related]
17. Population policies vary in Middle East.
Roudi N
Popul Today; 1993 Apr; 21(4):3, 10. PubMed ID: 12318175
[TBL] [Abstract][Full Text] [Related]
18. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
[TBL] [Abstract][Full Text] [Related]
19. Expanded programme on immunization (EPI). Immunization schedules in the WHO eastern Mediterranean region, 1995.
Wkly Epidemiol Rec; 1996 Jun; 71(23):173-6. PubMed ID: 8695338
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of hepatitis C in the Middle East.
Fallahian F; Najafi A
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):1-9. PubMed ID: 21196607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
